首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis.
【24h】

Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis.

机译:O6-甲基鸟嘌呤-DNA甲基转移酶基因在结肠癌进行过程中的甲基化模式。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

O(6)-methylguanine-DNA methyltransferase (MGMT) is a DNA repair gene which is frequently methylated in colorectal cancer (CRC). However, it remains controversial whether methylation of specific CpG sequences within MGMT promoter leads to loss of its protein expression, and if MGMT methylation correlates with G to A transition mutations in KRAS. Two methylation sensitive regions (Mp and Eh region) of MGMT promoter were investigated in 593 specimens of colorectal tissue: 233 CRCs, 104 adenomatous polyps (AP), 220 normal colonic mucosa from CRC patients (N-C) and 36 normal colonic mucosa specimens obtained from subjects without colorectal neoplasia (N-N) by combined bisulfite restriction analysis (COBRA). The region-specific methylation data were compared to the MGMT protein expression, spectrum of KRAS mutations and other clinical features. Extensive (including both Mp and Eh) and partial (either Mp or Eh) MGMT methylation were found in 24.5% and 11.6% of CRCs, 3.8% and 27.9% of APs, 0.5% and 7.7% of C-Ns and 2.8% and 2.8% of N-Ns, respectively. Extensive methylation of MGMT promoter was primarily present in CRCs while partial methylation was common in APs. Extensive methylation of MGMT promoter was associated with loss/reduced protein expression (p < 0.0001), as well as with G to A mutations in KRAS (p = 0.0017). We herein provide first evidence that extensive methylation of MGMT promoter region is essential for methylation-induced silencing of this gene. Our data suggest that MGMT methylation may evolve and spread throughout the promoter in a stepwise manner as the colonic epithelial cells progress through the classical-adenoma-cancer multistep cascade.
机译:O(6)-甲基鸟嘌呤-DNA甲基转移酶(MGMT)是一种DNA修复基因,在大肠癌(CRC)中经常被甲基化。但是,MGMT启动子内特定CpG序列的甲基化是否会导致其蛋白表达的丧失,以及MGMT甲基化是否与KRAS中的G到A转换突变相关,仍存在争议。在593个大肠组织标本中研究了MGMT启动子的两个甲基化敏感区(Mp和Eh区):233个CRC,104个腺瘤性息肉(AP),220个来自CRC患者(NC)的正常结肠黏膜和36个从结肠癌组织获得的正常结肠黏膜标本。合并亚硫酸氢盐限制分析(COBRA)的无结直肠肿瘤的患者(NN)。将区域特异性甲基化数据与MGMT蛋白表达,KRAS突变谱和其他临床特征进行比较。在CRC的24.5%和11.6%,AP的3.8%和27.9%,C-N的0.5%和7.7%,2.8%和2.8%的CRC中广泛(包括Mp和Eh)和部分(Mp或Eh)MGMT甲基化。 N-N分别为2.8%。 MGMT启动子的广泛甲基化主要存在于CRC中,而部分甲基化在AP中很常见。 MGMT启动子的广泛甲基化与蛋白质表达的丢失/减少(p <0.0001)以及KRAS中的G到A突变(p = 0.0017)有关。我们在此提供了第一个证据,即MGMT启动子区域的广泛甲基化对于该基因的甲基化诱导的沉默是必不可少的。我们的数据表明,随着结肠上皮细胞通过经典的腺瘤-癌症多步级联反应进展,MGMT甲基化可能以逐步的方式进化并遍及整个启动子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号